Enovix (NASDAQ:ENVX) Announces Earnings Results

Enovix (NASDAQ:ENVX) announced its quarterly earnings data on Wednesday. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02, FiscalAI reports. The firm had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 billion. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The business’s quarterly revenue was up 20.8% compared to the same quarter last year. During the same period last year, the company earned ($0.13) EPS. Enovix updated its Q3 2026 guidance to -0.170–0.130 EPS.

Here are the key takeaways from Enovix’s conference call:

• Enovix’s lead smartphone customer confirmed its cells surpassed 1,000 cycles in the 0.2C discharge test, an important qualification milestone. A final accelerated hybrid cycle-life test is underway, with completion expected by year-end 2026 before field testing and potential 2027 production.
• Smart eyewear entered early commercial revenue, with approximately 2,100 batteries shipped in Q2 and about 19,000 packs expected in Q3 as part of a 50,000-unit order. Management expects volumes to grow as customer deployments expand, although the business will likely pressure margins during its initial ramp.
• The South Korea-based drone, defense, and industrial pipeline grew 41% sequentially to approximately $183 million, including more than $100 million in drone opportunities and over $40 million in active testing or design-in stages. New capacity targeting roughly 1 million units annually is expected to come online in mid-2027.
• Q2 revenue rose 21% year over year to $9 million, while the company recorded its seventh consecutive quarter of positive gross profit and ended with approximately $552 million in cash and marketable securities. Enovix still posted a non-GAAP operating loss of $28.8 million and expects a $29 million-$32 million loss in Q3 as it continues investing in qualification and manufacturing scale-up.
• Manufacturing execution improved, with Fab2 integral yield increasing for the third consecutive quarter and Zone 1 dicing yield rising to approximately 84% from 80% in Q1. Management expects a hybrid laser-mechanical dicing configuration to materially improve throughput ahead of planned 2027 production volumes.

Enovix Trading Down 2.1%

NASDAQ ENVX opened at $4.73 on Thursday. Enovix has a 12 month low of $3.67 and a 12 month high of $14.21. The stock has a 50-day simple moving average of $5.47 and a 200 day simple moving average of $5.90. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. The company has a market capitalization of $1.03 billion, a PE ratio of -5.70 and a beta of 2.32.

Hedge Funds Weigh In On Enovix

Institutional investors have recently modified their holdings of the stock. Parallel Advisors LLC boosted its stake in Enovix by 51.9% during the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Enovix in the third quarter valued at approximately $80,000. Mercer Global Advisors Inc. ADV bought a new position in shares of Enovix during the third quarter worth $100,000. Mackenzie Financial Corp acquired a new position in shares of Enovix in the 4th quarter valued at $77,000. Finally, CIBC Asset Management Inc bought a new position in Enovix during the fourth quarter worth about $78,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix News Roundup

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix reported second-quarter adjusted EPS of a $0.13 loss, beating analysts’ expected $0.15 loss. Revenue reached $9.02 million, up 20.8% year over year and ahead of consensus estimates. Enovix Reports Second Quarter 2026 Results
• Positive Sentiment: Management continued to highlight potential demand for Enovix’s silicon-anode batteries across smartphones, wearables and defense applications. These markets could support longer-term growth if the company successfully scales production and converts customer interest into commercial orders. ENVX stock falls overnight despite Q2 beat
• Neutral Sentiment: For the third quarter, Enovix guided to an adjusted EPS loss of $0.17 to $0.13, broadly near the $0.15 consensus estimate. The company’s revenue outlook of $9 million to $10 million implies continued growth but remains below the approximately $10.3 million analyst expectation. Enovix Q2 2026 Earnings Call Transcript
• Negative Sentiment: Enovix remains deeply unprofitable, with a quarterly net margin of roughly negative 500% and a negative return on equity. The company also expects another quarterly loss, reinforcing concerns about the timing of profitability and the execution risks involved in scaling its battery technology. Enovix Reports Q2 Loss, Tops Revenue Estimates
• Negative Sentiment: The revenue-guidance shortfall appears to have outweighed the earnings beat, contributing to weaker investor sentiment. ENVX is trading below both its 50-day and 200-day moving averages, indicating continued technical pressure.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Craig Hallum lowered their price objective on Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Finally, Benchmark reduced their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Six investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Enovix has a consensus rating of “Hold” and a consensus price target of $12.50.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.